Q-omics provides the consensus-scored TRAV38-2DV8 profile across patient tissues and cancer cell-line models. Additionally, TRAV38-2DV8 RNA expression shows 14,436 significant protein co-abundance associations, with the highest sampling consensus in LSCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for TRAV38-2DV8 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

Locus: 14q11.2 &middot; T cell receptor alpha variable 38-2/delta variable 8
External: <a href="https://www.ncbi.nlm.nih.gov/gene/28643" target="_blank" rel="noopener" class="lin">NCBI Gene &middot; <a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000211817" target="_blank" rel="noopener" class="lin">Ensembl

This table shows molecular features associated with TRAV38-2DV8 in patient tissues and cancer cell lines. In patient samples, TRAV38-2DV8 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	14,436	LSCC (7909)	view →
Function (mass-spec)	1,459	LSCC (764)	view →